Narcolepsy

159 papers & discussions

A chronic neurological disorder causing excessive daytime sleepiness, sudden muscle weakness, and sleep disruption.

✦ AI summary

Here's what these sources say about narcolepsy: Narcolepsy type 1 involves a loss of the normal boundary between wakefulness and sleep, causing excessive daytime sleepiness, cataplexy (sudden muscle weakness), sleep paralysis, and vivid dream-like hallucinations; research points to an interaction between genetic immune-related susceptibility and environmental triggers (like certain infections, vaccination history, or head trauma) affecting orexin-producing brain cells [4]. Whether this is truly an autoimmune attack on those cells or an immune-triggered "silencing" of the relevant genes is still debated among researchers [11]. People with narcolepsy commonly have other health burdens too — higher rates of cardiovascular, metabolic, and kidney-related conditions [5], as well as back pain, headaches/migraine, and depression, with symptoms often persisting even when treated [12]. A large Italian patient registry found many people still have residual daytime sleepiness despite most receiving treatment [8]. Treatment research includes studies on oxybate medications, including newer low-sodium and extended-release formulations, which some studies report improve nighttime sleep, reduce sleepiness, and lessen

This is an AI-generated summary of the sources below — not medical advice. Always talk to a doctor or pharmacist about your own situation.

Excessive sleepinessCataplexySleep paralysisHallucinationsDisrupted night sleepBrain fog

Research

159
View all →
PubMed

The impact of insomnia and excessive daytime sleepiness on depression and suicidal ideation in adolescents: A three-year longitudinal study.

Insomnia and excessive daytime sleepiness (EDS) were associated with adverse mental health outcomes in adolescents, but their combined effects remained unclear. This study examined the associations between insomnia and EDS with mental health outcomes over a 3-year follow-up period. This study was a…

narcolepsy
Read on PubMed →
PubMed

Sleep disturbances in patients with vasculitis.

Research on sleep patterns in individuals with vasculitis remains limited. This SleepVasc study aimed to 1) evaluate sleep disturbances and a range of sleep health dimensions in individuals with vasculitis, and 2) identify potential risk factors for sleep problems/disturbances/disorders. SleepVasc w…

narcolepsyvasculitis
Read on PubMed →
PubMed

Narcolepsy type 1: an environment-influenced disease.

Narcolepsy type 1 (NT1) is a chronic and non-progressive neurological disorder that frequently arises in childhood. NT1 is characterized by loss of physiological boundaries between wakefulness and sleep, excessive daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic or hypnopompic hallucin…

narcolepsy
Read on PubMed →
PubMed

The use of oxybates in patients with comorbid narcolepsy and mental health disorders.

narcolepsy
Read on PubMed →
PubMed

The Italian registry for narcolepsy and central disorders of hypersomnolence (ReN&IS): Baseline clinical and diagnostic findings.

Central disorders of hypersomnolence, a wide and heterogeneous group of neurological disorders including narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH), are chronic, rare, under-recognized, and disabling conditions characterized by excessive daytime sleepiness (EDS…

narcolepsyidiopathic hypersomnia
Read on PubMed →
PubMed

Sleep and Substance Use Disorders: A Primer for the Clinician.

The neurophysiology of sleep and the pathophysiology of substance use disorders (SUDs) involve overlaps in neurotransmitters and pathways. SUDs and substance withdrawal are accompanied by significant impairments in sleep. Conversely, sleep disturbances are known to predispose for SUDs. Sleep disorde…

narcolepsy
Read on PubMed →
PubMed

Sodium-relevant comorbidity risk factors are highly prevalent in individuals with narcolepsy or idiopathic hypersomnia.

Individuals with narcolepsy or idiopathic hypersomnia (IH) present with a high comorbidity burden that may confer elevated risk for negative clinical outcomes associated with excess sodium intake. This study characterized the prevalence and profiles of sodium-relevant comorbidity risk factors among…

narcolepsyidiopathic hypersomnia
Read on PubMed →
PubMed

Assessment of readiness in the diagnosis and management of central disorders of hypersomnolence: A survey of sleep medicine program directors and fellowship graduates.

Central disorders of hypersomnolence (CDH), including narcolepsy, idiopathic hypersomnia, and recurrent hypersomnia, are rare conditions that pose challenges in sleep medicine fellowship training. Limited exposure to these disorders, variability in training experiences, and growing complexity of dia…

narcolepsyidiopathic hypersomnia
Read on PubMed →

People also search for

Idiopathic HypersomniaME/CFSBrain FogChronic FatigueFibromyalgia
Content sourced via official APIs from Reddit, YouTube, and PubMed. All sources link to originals. No personal health data is stored or profiled.